Insider · CIK 0001230486

ADAMS JULIAN

Reports to the SEC for 6 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001230486

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.8K sh	—	—	21,750
2025-05-19	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,900 sh	—	—	7,900
2024-11-21	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2024-01-31	Gamida Cell Ltd.A Award	Director	AAward	+200K sh	—	—	423,750
2023-12-28	ELTXElicio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2023-10-19	Gamida Cell Ltd.Share Option (Right to Buy)A Award	Director	AAward	+56.6K sh	—	—	56,600
2023-10-19	Gamida Cell Ltd.A Award	Director	AAward	+28.3K sh	—	—	223,750
2023-02-08	Gamida Cell Ltd.A Award	Director	AAward	+28.3K sh	—	—	223,750
2023-02-08	Gamida Cell Ltd.Share Option (Right to Buy)A Award	Director	AAward	+56.6K sh	—	—	56,600
2022-11-18	Gamida Cell Ltd.Share Option (Right to Buy)A Award	Director	AAward	+9,500 sh	—	—	9,500
2022-11-18	Gamida Cell Ltd.A Award	Director	AAward	+2,000 sh	—	—	195,450
2022-07-27	Gamida Cell Ltd.A Award	Director	AAward	+68.8K sh	—	—	193,450
2022-07-27	Gamida Cell Ltd.Employee Share Option (Right to Buy)A Award	Director	AAward	+291K sh	—	—	291,100
2022-07-27	Gamida Cell Ltd.A Award	Director	AAward	+48.5K sh	—	—	124,650
2018-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-10-31	INFINITY PHARMACEUTICALS, INC.A Award	President of R&D	AAward	+59.2K sh	—	—	59,150
2016-07-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2016-01-06	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+80K sh	—	—	80,000
2015-01-14	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+125K sh	—	—	125,000
2014-01-10	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+56.9K sh	—	—	56,900
2013-01-04	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+102K sh	—	—	101,780
2012-01-06	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+127K sh	—	—	126,850
2011-01-06	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+106K sh	—	—	106,210
2010-01-05	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+104K sh	—	—	104,000
2009-01-05	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+50K sh	—	—	50,000
2008-12-04	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+110K sh	—	—	110,000
2006-09-12	INFINITY PHARMACEUTICALS, INC.A Award	President of R&D	AAward	+126K sh	—	—	125,530
2006-09-12	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+54.7K sh	—	—	54,727
2006-09-12	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+54.7K sh	—	—	54,727
2006-09-12	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+331 sh	—	—	331
2006-09-12	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	President of R&D	AAward	+27.6K sh	—	—	27,628
2003-09-02	MILLENNIUM PHARMACEUTICALS INCEmployee stock option (right to buy)A Award	Senior Vice President	AAward	+25K sh	—	—	25,000
2003-08-26	MILLENNIUM PHARMACEUTICALS INCM Exercise/Conversion	Senior Vice President	MExercise/Conversion	+1,572 sh	$9.35	+$14.7K	4,716
2003-08-26	MILLENNIUM PHARMACEUTICALS INCM Exercise/Conversion	Senior Vice President	MExercise/Conversion	+1,572 sh	$8.27	+$13K	3,144
2003-08-26	MILLENNIUM PHARMACEUTICALS INCM Exercise/Conversion	Senior Vice President	MExercise/Conversion	+1,572 sh	$7.99	+$12.6K	1,572
2003-08-26	MILLENNIUM PHARMACEUTICALS INCEmployee stock option (right to buy)M Exercise/Conversion	Senior Vice President	MExercise/Conversion	−1,572 sh	—	—	6,762
2003-08-26	MILLENNIUM PHARMACEUTICALS INCS Sale	Senior Vice President	SSale	−7,841 sh	$13.06	−$102K	0
2003-08-26	MILLENNIUM PHARMACEUTICALS INCEmployee stock option (right to buy)M Exercise/Conversion	Senior Vice President	MExercise/Conversion	−1,572 sh	—	—	6,761
2003-08-26	MILLENNIUM PHARMACEUTICALS INCEmployee stock option (right to buy)M Exercise/Conversion	Senior Vice President	MExercise/Conversion	−1,572 sh	—	—	6,761
2003-08-26	MILLENNIUM PHARMACEUTICALS INCM Exercise/Conversion	Senior Vice President	MExercise/Conversion	+3,125 sh	$6.88	+$21.5K	7,841
2003-08-26	MILLENNIUM PHARMACEUTICALS INCEmployee stock option (right to buy)M Exercise/Conversion	Senior Vice President	MExercise/Conversion	−3,125 sh	—	—	21,875

Recent filings

Accepted (ET)
Sep 24
ADAMS JULIAN0001230486-26-000002
SEC(opens sec.gov)
May 204
ADAMS JULIAN0001601485-25-000087
SEC(opens sec.gov)
Nov 254
ADAMS JULIAN0001601485-24-000099
SEC(opens sec.gov)
Feb 24
ADAMS JULIAN0001415889-24-002328
SEC(opens sec.gov)
Dec 294
ADAMS JULIAN0001140361-23-060234
SEC(opens sec.gov)
Oct 204/A
ADAMS JULIAN0001209191-23-053245
SEC(opens sec.gov)
Feb 104
ADAMS JULIAN0001209191-23-008537
SEC(opens sec.gov)
Nov 224
ADAMS JULIAN0001209191-22-058386
SEC(opens sec.gov)
Aug 104
ADAMS JULIAN0001209191-22-045234
SEC(opens sec.gov)
Jan 294
ADAMS JULIAN0001562180-18-000483
SEC(opens sec.gov)
Jan 304
PIERIS PHARMACEUTICALS, INC.0000899243-17-002205
SEC(opens sec.gov)
Nov 24
INFINITY PHARMACEUTICALS, INC.0000899243-16-032622
SEC(opens sec.gov)
Jul 264
PIERIS PHARMACEUTICALS, INC.0000899243-16-025734
SEC(opens sec.gov)
Jan 84
INFINITY PHARMACEUTICALS, INC.0000899243-16-011390
SEC(opens sec.gov)
Jan 164
INFINITY PHARMACEUTICALS, INC.0001209191-15-004675
SEC(opens sec.gov)

Companies

Address

C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501

BOSTON, MA, 02210